Is This Elon's Worst Nightmare?
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.
FDA names longtime cancer scientist Pazdur to lead drug center
WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to lead the agency's drug center, replacing the who was recently ousted after an .
This Backdoor Energy Play Beat Gold by 15X - Ad
Gold has hit all-time highs, but one little-known energy play has seen 15x the return since the start of this year. It's all thanks to the incredible energy demands AI is putting on our country. It's a bull market hiding in plain sight, and 40-year Wall Street veteran Larry Benedict has found one company at the heart of it all.
As nations push for more ambition at climate talks, chairman says they may get it
BELEM, Brazil (AP) — Going into , the Brazilian hosts weren’t looking for big end-of-session pronouncements on lofty goals. This conference was supposed to hyperfocus on “implementation” of .
Biogen, Eisai File In Japan To Make Leqembi A Weekly At-Home Alzheimer's Shot
Eisai files for Japan approval of a weekly at-home Leqembi injection, offering an alternative to IV dosing and aiming to streamline Alzheimer's care.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Baxter Warns Of Potential Device Tampering In Life2000 Ventilator Recall
Baxter recalls its Life2000 ventilators after a cybersecurity flaw prompts an FDA high-risk alert, urging patients to stop use and seek replacement options.
BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review
BiomX works to address FDA device questions as a safety panel supports the BX004 trial, with topline results now expected in Q2 2026.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe
Sanofi faces a surprise tax probe in France as Dupixent secures EU approval for treating chronic spontaneous urticaria.
Novo Nordisk Alzheimer's Miss Disappointing But Not Material, Analyst Says
Novo Nordisk stock falls after disappointing results from Alzheimer's trial. Analysts remain cautious about future growth prospects.
Trump Triggered 70% Gains Overnight -- This Rare Earths Stock Could Be Next - Ad
Trump's turning tiny mining stocks into overnight fortunes... and this little-known rare earths miner could be his next billion-dollar BUY. If Trump cuts a deal you could see a 50% to 200% pop overnight. But you must act before the next deal hits the wire.
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Bayer's asundexian cut ischemic stroke risk without more bleeding, boosting FXIa optimism while raising fresh questions for Bristol Myers' milvexian program.
Here's what's next in the fight to curb climate change, now that talks in Brazil have ended
BELEM, Brazil (AP) — After from U.N. climate talks in the Amazon that fell short of many nations' expectations, experts found some bright spots alongside weighty reasons for worry in the fight against .
Nvidia CEO: E.I. Will Be as Common as Cars Today - Ad
E.I. isn't science fiction anymore. It's already here. And one little-known company is quietly supplying the systems behind it. This stock is still under Wall Street's radar... but not for long. You'll get the name, the ticker, and the full thesis inside.
Plan for $20 million firefighter training center near the site of Ohio derailment revived
Norfolk Southern railroad worked with the state of Ohio and Youngstown State University to revive plans for a $20 million first responder training center near the site of the in East Palestine, Ohio.
FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder
FDA reports rare neutralizing antibodies, including a pediatric death, in patients treated with Takeda's Adzynma for congenital TTP.
Is This Elon's Worst Nightmare? - Ad
Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Vanda's tradipitant cut Wegovy-related vomiting by 50% in a new trial, prompting bullish analyst views and price targets.
Activist Investor Drops Scathing Letter, Slams Cooper's 'Growth At All Costs' Approach
Browning West urges changes for underperforming Cooper Companies, highlighting weak oversight and misaligned incentives.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the on some store shelves.
Guterres and Lula to push negotiators at COP30 as deadline looms
BELEM, Brazil (AP) — Two global power players will spend Wednesday pushing negotiators to find compromises at in Brazil’s Belém, where a self-imposed deadline is rushing up fast.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer
Genmab's Epkinly receives traditional FDA approval for relapsed or refractory follicular lymphoma in combination and monotherapy. Clinical trial data show superior results.
Judge to explain why he's approving Purdue Pharma settlement plan, which calls for $7B from Sacklers
A U.S. Bankruptcy Court judge is set to give his reasoning Tuesday for approving OxyContin maker Purdue Pharma's plan to settle thousands of lawsuits over the toll of opioids.
The Market Just Crossed a Dangerous Line - Ad
The man who predicted the 2008 crash and 2020 says today's soaring markets are NOT a bubble - they're something far stranger and more dangerous. He says it's about to change everything you know about money.
AP Lifestyles Digest for week of Nov. 17
Here is the AP Lifestyles Digest for the week of Nov. 17. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.
Purdue Pharma's deal means money for some victims, end of Purdue company name. Here's what to know
A judge said Friday that he planned to approve a deal and members of the Sackler family who own the company to settle thousands of lawsuits over the toll of opioids, allowing money to start flowing to victims as soon as next spring.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
Climate leaders are talking about 'overshoot' into warming danger zone. Here's what it means
BELEM, Brazil (AP) — The world's climate leaders are conceding that will shoot past a hard limit they set a decade ago in hopes of keeping the planet out of a danger zone. But they're not conceding defeat.
Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients
Doritos and Cheetos are getting a makeover.
This Backdoor Energy Play Beat Gold by 15X - Ad
Gold has hit all-time highs, but one little-known energy play has seen 15x the return since the start of this year. It's all thanks to the incredible energy demands AI is putting on our country. It's a bull market hiding in plain sight, and 40-year Wall Street veteran Larry Benedict has found one company at the heart of it all.
UK commits to ensuring 'poignant' COVID memorial wall in London will be preserved
LONDON (AP) — The British government said Thursday that a memorial wall in London created by those who lost loved ones during the coronavirus pandemic will be preserved.
Zanzibar’s ‘solar mamas’ are trained as technicians to help light up communities
ZANZIBAR, Tanzania (AP) — When darkness came, so did the smoke.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks
Bayer's Q3 earnings rose on strong Crop Science and Pharma sales, with CEO Bill Anderson confident in meeting the company's upgraded 2025 guidance.
Climate change is in the news during COP30. We've got tips to tackle your climate anxiety
Every autumn, news feeds get flooded with stories about . That's because around this time each year, global leaders gather to discuss collective efforts to limit our emissions of planet-warming gases, released primarily from oil, gas and coal.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.